Skip to main content
OpenTrials
Completed

NCT Number: NCT01137617

Effect of Spinal Cord Stimulation on Pain Thresholds and Sensory Perception in Chronic Pain Patients.

The purpose of this study is to better understand how the Spinal Cord Stimulator works in relieving chronic pain.

The investigators are asking subject to take part in this study because who are chronic pain patients who already have a Spinal Cord Stimulator (SCS) in place.

The investigators hypothesize that chronic pain patients will have higher heat pain threshold and heat pain tolerance over the painful areas with the SCS on.

QST (Quantitative Sensory Testing, a heat/cold simulation test) might be an objective helpful tool for prudent patient selection for an expensive and invasive procedure for future SCS placement.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

MGH Center for Translational Pain Research

Boston, Massachusetts, 02114, United States

About this study

Sixty subjects who already have an implanted SCS device for pain management at the MGH Center for Pain Medicine and other Partners affiliated pain centers will be enrolled.

Inclusion criteria

  • Subject is 18 years or older.
  • Subject has an SCS device implanted for at least one month for pain control. This requirement is set to ensure that the subject becomes familiarized with the therapy and has recovered from the surgical implantation of the SCS device.

Exclusion criteria

  • Subject has neurological disease or a condition causing sensory deficit to the painful area.
  • Subject had recent therapy that may influence QST results, e.g., neuroablative procedure within two-months.
  • Subjects who are unable to travel to the study center.

It will be a one time outpatient visit study, which will include the following:

  • Brief pain history and Neurological examination
  • Medical History (including medication use);
  • Pain location, intensity, character and if known, etiology, duration;
  • Maps of pain locations and paresthesia locations;
  • Sensory neurological examination (e.g., alcohol swab, cotton swab, pinprick and vibration);
  • A check on routine vital signs (blood pressure, pulse, pulse oximetry).
  • QST will include the following:
  • Warm sensation, heat pain threshold, heat pain tolerance and wind-up. A cut-off of 53°C for heat will be preset to avoid tissue damage.
  • QST will be done on two areas; painful area and non-painful area without paresthesia with the SCS turned off.
  • Subject will then turn on SCS and a repeat QST will be performed on the painful and non-painful areas.
  • QST tests will be performed in a quiet room at temperature 25º 2° C. The time and duration of the QST tests will be recorded.

QST will be performed at least 4 hours and no later than 6 hours after the last dose of long acting opioid and after last SCS on time. In this way the investigators will try to avoid recording possible end dose withdrawal and provide sufficient time for the subject to return to baseline for their SCS therapy.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subject is 18 years or older.
  • Subject has an SCS device implanted for at least one month for pain control. This requirement is set to ensure that the subject becomes familiarized with the therapy and has recovered from the surgical implantation of the SCS device.

Exclusion criteria

  • Subject has neurological disease or a condition causing sensory deficit to the painful area.
  • Subject had recent therapy that may influence QST results, e.g., neuroablative procedure within two-months.
  • Subjects who are unable to travel to the study center.

Treatment and study plan

Primary outcomes

  1. Warm Sensation (WS) Threshold- Pain Site

    Time frame: WS threshold is assessed once at Visit 1

    WS threshold is a type of Quantitative Sensory Test (QST). A contact thermode was attached to the subject's painful area that has SCS coverage. The thermode increased by 1°C/sec from a baseline of 32°C. Subjects were instructed to stop stimulation when they first perceived a warm sensation. Subjects performed this test with their SCS off and again with their SCS on.

  2. Heat Pain (HP) Threshold- Pain Site

    Time frame: HP threshold is assessed once at Visit 1

    Heat Pain threshold is a type of QST. A contact thermode was attached to the subject's painful area that has SCS coverage. The thermode increased by 1°C/sec from a baseline of 32°C. Subjects were instructed to stop the stimulation when pain was first detected. Subjects performed this test with their SCS off and again with their SCS on.

  3. Heat Pain Tolerance- Pain Site

    Time frame: Heat Pain Tolerance is assessed once at Visit 1

    Heat Pain threshold is a type of QST. A contact thermode was attached to the subject's painful area that has SCS coverage. The thermode increased by 1°C/sec from a baseline of 32°C. Subjects were instructed to stop the stimulation when pain was no longer tolerable. Subjects performed this test with their SCS off and again with their SCS on.

Sponsors and collaborators

Lead sponsor

Massachusetts General Hospital

Other

Registry information

Acronym: SCS

Important dates

Study start
2010
Primary completion
2011
Study completion
2016
First posted
Jun 4, 2010
Registry last updated
Jul 22, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.